Home » Newsletters » BioWorld Science

BioWorld Science

June 19, 2014

View Archived Issues

Results from phase I trial of PF-06438179, a biosimilar to infliximab

ABP-501 proves equivalent to adalimumab in healthy volunteers

NNC-0151-0000 development halted, second-generation compound shows improved profile

Selexipag meets endpoint in pivotal phase III study in PAH

Inovio Pharmaceuticals expands license agreement with the University of Pennsylvania

Phase III perampanel trial meets primary endpoint in primary generalized tonic-clonic seizures

Isis Pharmaceuticals earns milestone payment under Biogen Idec collaboration

PsiOxus initiates phase I/II study of enadenotucirev for ovarian cancer

GW Pharmaceuticals reports expanded-access data for Epidiolex

Eculizumab receives U.S. orphan drug designation for myasthenia gravis

FDA award orphan drug designation to COTI-2 for ovarian cancer

Senhwa Biosciences begins phase I/II trial of CX-4945

Galapagos provides progress update on R&D programs

Bioequivalence of LY-2963016 to originator insulin glargine

GlaxoSmithKline presents new IFN-alpha inducers

GlaxoSmithKline describe novel DGAT1 inhibitors

Novel phosphodiesterase PDE10A inhibitors synthesized at Merck & Co.

Piramal Enterprises patents new proinflammatory cytokine inhibitors

Enrollment complete in phase IIa trial of GALE-301 immunotherapy in gynecological cancer

New IDO inhibitors prepared by Vertex Pharmaceuticals

Immunomodulator HMPL-523 enters first-in-human trial

Selecta Biosciences outlines pipeline progress and reveals new product candidate

Endocyte regains rights to vintafolide

Allergan acknowledges second unsolicited exchange offer from Valeant

BMS-817399 fails to improve rheumatoid arthritis in phase II proof-of-concept study

Takeda terminates development of orteronel for prostate cancer

Boehringer Ingelheim and Lilly resubmit empagliflozin NDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...